Contribution of sec61α to the life cycle of Ebola virus

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Iwasa, Ayaka ^a   Halfmann, Peter ^b   Noda, Takeshi ^a   Oyama, Masaaki ^a   Kozuka Hata, Hiroko ^a   Watanabe, Shinji ^c   Shimojima, Masayuki ^c   Watanabe, Tokiko ^c   Kawaoka, Yoshihiro ^a,b,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SEC61ALPHA; PROTEIN VP24; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EBOLA VIRUS; ENZYME INHIBITION; FATTY LIVER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS RELEASE; VIRUS REPLICATION;

EBOLAVIRUS; GENE SILENCING; GENOME, VIRAL; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 80054770820     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir324     Document Type: Article

References (34)

1. Elliott LH, Kiley MP, McCormick JB. Descriptive analysis of Ebola virus proteins. Virology 1985; 147:169-76. (Pubitemid 16200579)
2. Han Z, Boshra H, Sunyer JO, Zwiers SH, Paragas J, Harty RN. Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J Virol 2003; 77:1793-800. (Pubitemid 36109991)
3. Huang Y, Xu L, Sun Y, Nabel GJ. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 2002; 10:307-16. (Pubitemid 35007345)
4. Hoenen T, Groseth A, Kolesnikova L, et al. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol 2006; 80:7260-4. (Pubitemid 44025222)
5. Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J Infect Dis 2007; 196:S284-90. (Pubitemid 351417273)
6. Reid SP, Leung LW, Hartman AL, et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol 2006; 80:5156-67.
7. Reid SP, Valmas C, Martinez O, Sanchez FM, Basler CF. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol 2007; 81:13469-77. (Pubitemid 350252964)
8. Görlich D, Prehn S, Hartmann E, Kalies KU, Rapoport TA. A mammalian homolog of SEC61p and SECYp is associated with ribosomes and nascent polypeptides during translocation. Cell 1992; 71:489-503.
9. Greenfield JJ, High S. The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. J Cell Sci 1999; 112:1477-86. (Pubitemid 29261310)
10. Römisch K. Surfing the Sec61 channel: bidirectional protein translocation across the ER membrane. J Cell Sci 1999; 112:4185-91. (Pubitemid 30122011)
11. Koopmann JO, Albring J, Hüter E, et al. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 2000; 13:117-27.
12. Kanuka H, Hiratou T, Igaki T, et al. Gain-of-function screen identifies a role of the Sec61alpha translocon in Drosophila postmitotic neurotoxicity. Biochim Biophys Acta 2005; 1726:225-37. (Pubitemid 41670644)
13. Wang X, Ward RE 4th. Sec61alpha is required for dorsal closure during Drosophila embryogenesis through its regulation of Dpp signaling. Dev Dyn 2010; 239:784-97.
14. Lloyd DJ, Wheeler MC, Gekakis N. A point mutation in Sec61alpha1 leads to diabetes and hepatosteatosis in mice. Diabetes 2010; 59:460-70.
15. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 2007; 196:S347-56. (Pubitemid 351417281)
16. Watanabe S, Noda T, Kawaoka Y. Functional mapping of the nucleoprotein of Ebola virus. J Virol 2006; 80:3743-51.
17. Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol 2001; 75:5205-14. (Pubitemid 32448543)
18. Niwa H, Yamamura K, Miyazaki J. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 1991; 108:193-200.
19. Kobasa D, Rodgers ME, Wells K, Kawaoka Y. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol 1997; 71:6706-13. (Pubitemid 27355330)
20. Watanabe S, Watanabe T, Noda T, et al. Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol 2004; 78:999-1005. (Pubitemid 38067621)
21. Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 1999; 73:8907-12. (Pubitemid 29441763)
22. Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 2002; 76:406-10. (Pubitemid 33139025)
23. Neumann G, Watanabe T, Ito H, et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 1999; 96:9345-50. (Pubitemid 29374757)
24. Nakatani Y, Ogryzko V. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol 2003; 370:430-44. (Pubitemid 37542800)
25. Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008; 454: 890-3.
26. Halfmann P, Kim JH, Ebihara H, et al. Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 2008; 105:1129-33. (Pubitemid 351397018)
27. Takada A, Robison C, Goto H, et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 1997; 94:14764-9. (Pubitemid 28041448)
28. Shimojima M, Takada A, Ebihara H, et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006; 80:10109-6.
29. Mühlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 1999; 73:2333-42. (Pubitemid 29098138)
30. Noda T, Ebihara H, Muramoto Y, et al. Assembly and budding of Ebolavirus. PLoS Pathog 2006; 2:e99.
31. Noda T, Halfmann P, Sagara H, Kawaoka Y. Regions in Ebola virus VP24 that are important for nucleocapsid formation. J Infect Dis 2007; 196:S247-50. (Pubitemid 351417267)
32. Sanchez A, Geisbert TW, Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, eds. Fields Virology, 5th ed. Philadelphia: Lippincott Wiliams & Wilkins, 2006; 1409-48.
33. Johnson RF, McCarthy SE, Godlewski PJ, Harty RN. Ebola virus VP35- VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles. J Virol 2006; 80:5135-44.
34. Groseth A, Charton JE, Sauerborn M, et al. The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res 2009; 140:8-14